Admedus is a structural heart company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Its focus is on investing in and developing next generation technologies with world class partners and acquiring strategic assets to grow product and service offerings. The company has assets from research & development through clinical development and sales, marketing and distribution.


LATEST NEWS


FIRST-IN-HUMAN SAVR TRIAL BEGINS Q1 2020
ANNOUNCEMENT FIRST-IN-HUMAN SAVR TRIAL BEGINS Q1 2020 Admedus Limited (AHZ or the Company) announces approval for first-in-human surgical aortic valve...
Read more.

Feburary #heartmonth, we stay committed in rising awareness of Heart Symptoms: a heart murmur, chest tightness, sho… https://t.co/ECEMeXFoio
Admedus will be hosting a Q&A call for #investors to learn more about our 3D aortic valve development – hosted by C… https://t.co/axMzT5Ohv3
With the largest number of #TAVR and #Mitral cases ever presented at #PCRTokyo valves and with a growing number of… https://t.co/0GTPaVSFE3